Featured Research

from universities, journals, and other organizations

Viral Mimic Induces Melanoma Cells To Digest Themselves

Date:
August 12, 2009
Source:
Cell Press
Summary:
Recent research has uncovered an unexpected vulnerability in deadly melanoma cells that, when exploited, can cause the cancer cells to turn against themselves. The study identifies a new target for development of future therapeutics aimed at selectively eliminating this aggressive skin cancer which is characterized by a notoriously high rate of metastasis and treatment-resistance.

Recent research has uncovered an unexpected vulnerability in deadly melanoma cells that, when exploited, can cause the cancer cells to turn against themselves. The study, published in the August issue of the journal

Cancer Cell,

identifies a new target for development of future therapeutics aimed at selectively eliminating this aggressive skin cancer which is characterized by a notoriously high rate of metastasis and treatment-resistance.

"Although considerable effort has been devoted to the search for molecular mechanisms that contribute to the chemo- and immunoresistance of melanoma, the average survival of patients with inoperable metastases remains less than 10 months," explains senior study author Dr. Maria S. Soengas from the Melanoma Laboratory at the Spanish National Cancer Research Centre in Madrid, Spain. Melanoma has multiple complex genetic aberrations that make the cells difficult to destroy with current treatments.

One process that has not been studied in great detail with regards to melanoma is a type of autophagy (literally, self-eating) that involves sequestration of components within the cell for eventual degradation. Previous work has linked autophagy with both cancer cell death and survival and it is not clear whether this process might be a viable target for future drug development. Dr. Soengas and colleagues designed a series of studies to examine the interplay between autophagy and cell death in the context of tumor cell-selective elimination of melanoma cells.

The researchers discovered that melanoma cells retain the ability to recognize and respond to double-stranded RNA (dsRNA) located inside the cell cytoplasm. Most animal cells contain single-stranded RNA and see dsRNA, which is associated with viruses, as a threat. The melanoma cells responded to administration of the dsRNA mimic polyinosine-polycytidylic acid (pIC) by inducing an immune response that led to autophagy. However, the method of delivering the pIC to the melanoma cells was critical and required a carrier called polyethyleneimine (PEI) to ensure delivery of pIC to the cell cytoplasm.

The researchers went on to show that pIC links autophagy to apoptosis, a well studied cell death pathway. Significantly, the cell autonomous anti-tumor activity of pIC was observed even in animals with a suppressed immune system, a condition common to melanoma patients. "Altogether, our results provide the proof of principle for dsRNA sensors as therapeutic targets to overcome the inherent resistance of melanoma cells to current anticancer treatments," says Dr. Soengas.

Importantly, the pIC-PEI complex has two exciting advantages over other anticancer agents. "First, pIC-PEI can induce both autophagy and apoptosis in an efficient manner while other compounds are just partial inducers of one of the two processes. Second, pIC-PEI has a significant anti-melanoma activity in experimental mouse models without noticeable side effects." The researchers caution that further research is required before these results can be translated to the clinic.

The researchers include Damia` Tormo, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Agnieszka Checinska, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Direna Alonso-Curbelo, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Eva Perez-Guijarro, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Estela Canon, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Erica Riveiro-Falkenbach, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Tonantzin G. Calvo, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Lionel Larribere, Spanish National Cancer Research Centre (CNIO), Madrid, Spain' Diego Megias, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Francisca Mulero, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Miguel A. Piris, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Rupesh Dash, Virginia Commonwealth University, School of Medicine, Richmond, VA; Paola M. Barral, Virginia Commonwealth University, School of Medicine, Richmond, VA; JoseŽ L. Rodriguez-Peralto, Hospital Universitario, Madrid, Spain; Pablo Ortiz-Romero, Hospital Universitario, Madrid, Spain; Thomas Tuting, University of Bonn, Bonn, Germany; Paul B. Fisher, Virginia Commonwealth University, School of Medicine, Richmond, VA; and Maria S. Soengas, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Viral Mimic Induces Melanoma Cells To Digest Themselves." ScienceDaily. ScienceDaily, 12 August 2009. <www.sciencedaily.com/releases/2009/08/090803122717.htm>.
Cell Press. (2009, August 12). Viral Mimic Induces Melanoma Cells To Digest Themselves. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2009/08/090803122717.htm
Cell Press. "Viral Mimic Induces Melanoma Cells To Digest Themselves." ScienceDaily. www.sciencedaily.com/releases/2009/08/090803122717.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) — A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins